DiaSys Diagnostic Systems, a diagnostics company based in Rhineland-Palatinate, Germany, has expanded its portfolio with the instruction of an immunoturbidimetric test for quantitative determination of total antibodies in COVID-19. This universally applicable total antibody test, called SARS-CoV-2 UTAB FS (UTAB = Universal Total AntiBody), enables the detection SARS CoV-2 antibodies to check whether a person […]
https://clinlabint.com/wp-content/uploads/sites/2/2021/03/3_PRODUCT_DIASYS.jpg407529DiaSys Diagnostic Systems GmbHhttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.pngDiaSys Diagnostic Systems GmbH2021-03-29 10:52:212021-03-30 11:27:45DiaSys expands portfolio with universally applicable assay for antibody determination in COVID-19
With the VACUETTE FC Mix tube from Greiner Bio-One, stabilization for up to 48 hours is possible immediately after collection. This enables longer transport and storage times.
https://clinlabint.com/wp-content/uploads/sites/2/2021/03/4_PRODUCT_GREINER_BIO-ONE.jpg582676Greiner Bio-One GmbHhttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.pngGreiner Bio-One GmbH2021-03-29 10:49:122021-03-30 10:52:08Greiner Bio-One’s VACUETTE FC Mix Tube provides glucose stabilization right from the start
Torrey Pines Scientific, has released its new EchoTherm HPLC Column Oven Model CO20. The temperature range is from room temperature to 90°C readable and settable to 0.1°C. The PID temperature control software regulates temperatures to ±0.1°C. Temperature accuracy and stability are ±0.1ºC with a stable temperature indicator lamp on the front panel that lights when […]
Tecan has launched the Frida Reader for the Fluent Automation Workstation, offering researchers the ability to quantify nucleic acids without sample loss. This unique solution performs UV absorbance-based quantification and purity assessment in a hanging drop, avoiding the consumption of rare and precious samples following nucleic acid purification (NAP). This latest offering further expands Tecan’s […]
https://clinlabint.com/wp-content/uploads/sites/2/2021/03/7_PRODUCT_TECAN.jpg368726Tecanhttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.pngTecan2021-03-29 10:39:492021-03-30 10:43:55Tecan eliminates nucleic acid sample loss with new Frida Reader
Shimadzu, one of the world leaders in analytical instrumentation, has released its “Advanced i-Series” liquid chromatographs. The Prominence-i HPLC and Nexera-i UHPLC systems feature pressures of 50 MPa or 70 MPa respectively and can be combined with a variety of detectors. The Advanced i-Series meets user demands for analyzing a large number of samples or […]
https://clinlabint.com/wp-content/uploads/sites/2/2021/03/8_PRODUCT_SHIMADZU.jpg13951000Shimadzu Europa GmbHhttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.pngShimadzu Europa GmbH2021-03-29 10:11:562021-03-30 10:39:41Shimadzu releases new Advanced i-Series liquid chromatographs
Horiba Medical, specialists in automated in vitro diagnostic systems for haematology, haemostasis and clinical chemistry analysis, has obtained the CE Mark certification for its new generation of the Microsemi CRP haematology analyser, the Microsemi CRP LC-767G.
https://clinlabint.com/wp-content/uploads/sites/2/2021/03/10_PRODUCT_HORIBA.jpg956756HORIBA Medicalhttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.pngHORIBA Medical2021-03-29 09:50:132021-03-30 10:33:17Horiba Medical obtains CE Mark for new generation Microsemi CRP LC-767G
Waters Corporation has introduced the Waters Acquity Premier Solution, the next generation in liquid chromatographs featuring Waters’ breakthrough MaxPeak High Performance Surface (HPS) technology. The solution leverages HPS to vastly improve analytical data quality and eliminate the need for timeconsuming and costly passivation.
AMSBIO has introduced a collection of mutated SARS-CoV-2 spike proteins and recombinant antigens for the new virus variants – B.1.1.7 and B.1.351. These reagents can be used by researchers to evaluate the efficacy of the antibodies and identify targets for development of improved therapeutic drugs and vaccines.
Thermo Scientific has introduced the Orbitrap Exploris GC 240 – a new gas chromatography (GC) high-resolution mass spectrometer (MS) with unrivalled mass resolving power, sensitivity and wide dynamic range.
The GC addresses the need for increased flexibility, speed and accuracy in research applications throughout academic and industry laboratories, and offers researchers the capability to achieve new depths of analysis and drive scientific understanding. With new-generation system architecture and instrument control software, the system provides simple yet powerful data acquisition capabilities.
Research power
The Orbitrap Exploris GC 240 MS takes research capabilities to a new level with a resolving power of 240,000, for accelerated innovation. By delivering both quantitative and qualitative information from a single injection, the new system enables precise and comprehensive compound identification, allowing researchers to make fast and accurate discoveries with confidence. As research laboratories require the versatility to answer myriad questions in their studies, the Orbitrap Exploris GC 240 MS also provides the flexibility to tackle a diverse range of analytical challenges, from identifying unknown contaminants and extractables and leachables, to applied quantification and metabolomics. The system offers the capability of MS/MS for compound structural information and both electron and chemical ionization without system venting to speed up time to result.
User benefits
Users of the Orbitrap Exploris GC 240 MS will benefit from:
Analytical dynamic range across six orders, providing accurate quantitation and detection of chemical components at trace and high concentrations
Standardized setup and easy-to-use system for users with varied levels of technical experience
Informatics solutions for targeted quantitation and profiling, such as the Thermo Scientific Chromeleon Chromatography Data System (CDS) software, which enables seamless data acquisition to reporting in targeted analysis. For profiling and discovery, the Thermo Scientific Compound Discoverer 3.2software enables researchers to discover sample differences, perform spectral matching and make proposed identifications of unknown compounds
Use of commercially-available spectral libraries for spectral matching, plus the use of application-specific high resolution accurate mass libraries in the Thermo Scientific Orbitrap GC-MS contaminants library and the Thermo Scientific Orbitrap GC-MS HRAM metabolomics library
Compact platform with a smaller footprint than existing systems.
Orbitrap Exploris portfolio
The new system, along with the Thermo Scientific Orbitrap Exploris GC, extends the Thermo Scientific Orbitrap Exploris portfolio of high-resolution accurate mass systems, which is now comprised of the Thermo Scientific Orbitrap Exploris 480 mass spectrometer, launched in 2019, and the recently introduced Thermo Scientific Orbitrap Exploris 240 and Thermo Scientific Orbitrap Exploris 120 mass spectrometers.
PCR Biosystems, the UK-based specialists in DNA and RNA analysis, have launched a range of IsoFast Bst Polymerase reagents for rapid, robust and sensitive DNA and RNA amplification. Through its nucleic acid strand displacement capabilities, Bst polymerase eliminates the need for the high temperature denaturation step associated with traditional Taq enzymes. This enables faster time to result and facilitates DNA and RNA amplification in the field without specialised thermocycling equipment.
The new range of IsoFast Bst reagents from PCR Biosystems can be used for a variety of techniques including whole genome amplification, multiple displacement amplification and isothermal amplification. Such techniques have important applications in sectors ranging from environmental and food pathogen testing to clinical diagnostics and next generation sequencing. Scientists performing DNA and RNA amplification using IsoFast Bst Polymerase can benefit from consistent results over a wide dynamic range and sensitivities down to 3 copies of target DNA (10fg).
To continue PCR Biosystems’s support of the global fight against COVID-19, the Bst Polymerase reagents have been validated for qualitative detection of the SARS-CoV-2 nucleic acid. Combined with the reagents’ suitability for use in the field, this validation opens the potential for rapid SARS-CoV-2 testing in environments such as airports, hospitals or care homes, without the need for a central laboratory, delivering results in 30 minutes and supporting initiatives for community or regular testing to safeguard public health. Sensitivities down to 12 copies of SARS-CoV-2 targets can be achieved, providing confidence in the quality and accuracy of results.
“DNA and RNA amplification has been a staple technique in the scientific toolbox for more than 40 years, and with its application for SARS-CoV-2 diagnostic testing, there has been an increased demand for rapid and reliable reagents for mass testing,” says Alex Wilson, co-founder of PCR Biosystems. “The launch of the IsoFast Bst Polymerase range aligns with our commitment to provide robust solutions to support COVID-19 testing and will continue to expand diagnostic capabilities for viruses such as Zika and Ebola long after the COVID-19 pandemic.”
While many supply chains have been disrupted due to the pandemic, PCR Biosystems continues to scale up and optimise operations to provide consistent, reliable supplies to customers, ensuring laboratories have the critical DNA and RNA analysis reagents needed for uninterrupted research and diagnostics.
The IsoFast Bst range is available in flexible formats, with 2X mix formats streamlining set up for high throughput applications and components available separately for those customers wanting to optimise the reaction for their specific needs. Furthermore, the reagents are offered with optional fluorescent dyes, facilitating real-time amplification tracking.
https://clinlabint.com/wp-content/uploads/sites/2/2021/03/PCR-Biosystems-IsoFast-Bst-Polymerase.jpg15002000panglobalhttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.pngpanglobal2021-03-26 09:18:512021-03-26 09:18:51PCR Biosystems unveils advanced Bst Polymerase reagents for accelerated DNA and RNA amplification
We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.
Google Analytics Cookies
These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
Other external services
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.
Privacy Beleid
U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
